Clinical Inertia in the Management of Low‐Density Lipoprotein Abnormalities in an HIV Clinic | Zendy

James H. Willig | Zendy; David A. Jackson | Zendy; Andrew O. Westfall | Zendy; Jeroan J. Allison | Zendy; P. W. Chang | Zendy; James L. Raper | Zendy; Michael S. Saag | Zendy; Michael J. Mugavero | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical Inertia in the Management of Low‐Density Lipoprotein Abnormalities in an HIV Clinic

Author(s) -

James H. Willig,

David A. Jackson,

Andrew O. Westfall,

Jeroan J. Allison,

P. W. Chang,

James L. Raper,

Michael S. Saag,

Michael J. Mugavero

Publication year - 2008

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/533466

Subject(s) - medicine , coronary heart disease , retrospective cohort study , human immunodeficiency virus (hiv) , cohort study , cohort , lipoprotein , physical therapy , cholesterol , immunology

A retrospective cohort study evaluating the frequency of and factors related to clinical inertia in low-density lipoprotein (LDL) management was performed. Subjects were 90 patients that were not meeting National Cholesterol Education Program Adult Treatment Panel III LDL goals at the University of Alabama at Birmingham 1917 HIV/AIDS Clinic between 1 August 2004 and 1 August 2005. Clinical inertia was observed in 44% of cases. Patients with higher baseline LDL levels were less likely to experience inertia, whereas women and those in the highest coronary heart disease risk category were more likely to be affected.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research